WO/2017/029594 PROCESSES FOR PREPARATION OF SELEXIPAG AND ITS AMORPHOUS FORM||WO||23.02.2017|
||PCT/IB2016/054858||DR. REDDY'S LABORATORIES LIMITED||ORUGANTI, Srinivas|
The present application relates to processes for preparation of Selexipag, its amorphous form, amorphous solid dispersion and pharmaceutical composition thereof. Formula (I):
WO/2017/023361 PHARMACEUTICAL COMPOSITION COMPRISING SUMATRIPAN FOR TREATING MIGRAINE||WO||09.02.2017|
||PCT/US2016/015961||DR. REDDY'S LABORATORIES LTD.||PRABHAKARA, Prabhu|
The present application relates to a method of treating migraine or cluster headache in a human patient, said method comprising administering subcutaneously composition comprising sumatriptan or its pharmaceutically acceptable salt, in an amount equivalent to 3 mg sumatriptan base.
WO/2017/021871 A CELL CULTURE PROCESS FOR MODULATING GLYCANS||WO||09.02.2017|
||PCT/IB2016/054629||DR. REDDY'S LABORATORIES LIMITED||CHANDRASEKAR RAJU, Nirmala|
The invention describes a cell culture process for modulating percentage of high mannosylated and afucosylated glycans wherein the cell culture process comprises culturing cells in a culture medium and supplementing cell culture with manganese.
WO/2017/011600 TOPICAL RETINOID COMPOSITIONS||WO||19.01.2017|
||PCT/US2016/042168||DR. REDDY'S LABORATORIES, LTD.||KADAVILLI, Sateesh|
The present application relates to topical compositions. In particular, the present application relates to a topical composition comprising retinoid as active agent, and pharmaceutically acceptable excipient(s), and a process of preparing such compositions. Further, the present application relates to method of using topical compositions for the treatment of skin disorders such as acne, rosacea, psoriasis etc.
WO/2017/006290 MODIFIED RELEASE NICERGOLINE COMPOSITIONS||WO||12.01.2017|
||PCT/IB2016/054111||KUNSHAN ROTAM REDDY PHARMACEUTICAL CO., LTD||RAGHUVANSHI, Rajeev Singh|
The present application relates to a modified release composition comprising nicergoline, or its pharmaceutically acceptable salt thereof, at least one rate-controlling polymer and one or more other pharmaceutically acceptable excipients. The present application also relates to a modified release composition that provides steady plasma concentrations with minimal fluctuations and offer convenient dosing (i.e., dosed less frequently).
WO/2016/207824 A STABLE PHARMACEUTICAL COMPOSITION COMPRISING RAMIPRIL AND/OR AMLODIPINE||WO||29.12.2016|
||PCT/IB2016/053738||DR. REDDY'S LABORATORIES LTD||RAGHUVANSHI, Rajeev Singh|
The present invention relates to a stable pharmaceutical composition comprising a fixed-dose combination of amlodipine and ramipril, and a pharmaceutically acceptable excipient. Further, the present invention relates to a process of preparing such compositions and method of using in the treatment of cardiovascular disorders.
WO/2016/203436 AMORPHOUS AND AMORPHOUS SOLID DISPERSION OF LESINURAD AND THEIR PREPARATION||WO||22.12.2016|
||PCT/IB2016/053605||DR. REDDY'S LABORATORIES LIMITED||KANDAGATLA, Bhaskar|
The present invention provides amorphous form of lesinurad, amorphous solid dispersion of lesinurad and processes for preparation thereof. The present invention also provides a pharmaceutical composition comprising amorphous or amorphous solid dispersion of lesinurad and one or more pharmaceutically acceptable excipient or carrier.
WO/2016/199020 PROCESS FOR PREPARATION OF CERITINIB||WO||15.12.2016|
||PCT/IB2016/053339||DR. REDDY'S LABORATORIES LIMITED||MURKI, Veerender|
The present application relates to a process for preparation of ceritinib and intermediates thereof. Specifically, the present application relates to a process for preparation of N-(4-(1-benzyl- 1,2,3,6-tetrahydropyridin-4-yl)-2-isopropoxy-5-methylphenyl)acetamide (VC) comprising treating N-(4-(bromomethyl)-2-isopropoxy-5-methylphenyl)acetamide (IIID) with 1- benzylpiperidin-4-one (IVA). The present application also relates to a process for conversion of N-(4-(1-benzyl-1,2,3,6-tetrahydropyridin-4-yl)-2-isopropoxy-5-methylphenyl)-acetamide (VC) to ceritinib or an acid-addition salt thereof.
WO/2016/191744 ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN||WO||01.12.2016|
||PCT/US2016/034844||DR. REDDY'S LABORATORIES LTD.||BAHETI, Ankit|
The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted- State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37°C ± 0.5°C and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
WO/2016/162754 PHARMACEUTICAL COMPOSITIONS FOR MINOCYCLINE||WO||13.10.2016|
||PCT/IB2016/000553||DR. REDDY'S LABORATORIES LTD.||LOWALEKAR, Rohit|
The present application relates to a method of orally administering once daily tablet of minocycline to a subject in need thereof, wherein said tablet is substantially free of lactose. The present application also relates to processes for preparing said once daily tablet of minocycline that provides reduced stock keeping units with improved inventory by supplying multiple doses of minocycline in single tablet.